Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach
Abstract Background Data monitoring of clinical trials is a tool aimed at reducing the risks of random errors (e.g. clerical errors) and systematic errors, which include misinterpretation, misunderstandings, and fabrication. Traditional ‘good clinical practice data monitoring’ with on-site monitors...
Main Authors: | Markus Harboe Olsen, Mathias Lühr Hansen, Sanam Safi, Janus Christian Jakobsen, Gorm Greisen, Christian Gluud, The SafeBoosC-III Trial Group |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | BMC Medical Research Methodology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12874-021-01344-4 |
Similar Items
-
Alternative consent methods used in the multinational, pragmatic, randomised clinical trial SafeBoosC-III
by: Maria Linander Vestager, et al.
Published: (2024-04-01) -
Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants
by: Markus Harboe Olsen, et al.
Published: (2023-11-01) -
The effects of cerebral oximetry in mechanically ventilated newborns: a protocol for the SafeBoosC-IIIv randomised clinical trial
by: Maria Linander Vestager, et al.
Published: (2023-10-01) -
Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial.
by: Anne M Plomgaard, et al.
Published: (2017-01-01) -
Pilot test of an online training module on near-infrared spectroscopy monitoring for the randomised clinical trial SafeBoosC-III
by: Mathias Lühr Hansen, et al.
Published: (2020-04-01)